Back
Vertex Pharmaceuticals Vs. IperionX Industry Stock Comparison
Sell
49
VRTX
Vertex Pharmaceuticals
Last Price:
$405.90
Seasonality Move:
-0.59%
Buy
85
IPX
IperionX
Last Price:
$35.30
Seasonality Move:
35.72%
Sell
49
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
-
The current Vertex Pharmaceuticals [VRTX] share price is $402.70. The Score for VRTX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $402.70Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight selling pressure.
IPX Stock Price Chart
VRTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -18.07 | Sell |
Relative Strength Index (14 RSI): | 31.24 | Sell |
Chaikin Money Flow: | 147663 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
IPX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.96 | Buy |
Relative Strength Index (14 RSI): | 64.31 | Buy |
Chaikin Money Flow: | -26273 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
VRTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 403.6 | Sell |
20-day SMA: | 439.8 | Sell |
50-day SMA: | 461.09 | Sell |
200-day SMA: | 457.02 | Sell |
8-day EMA: | 411.88 | Sell |
20-day EMA: | 431.52 | Sell |
50-day EMA: | 451.53 | Sell |
200-day EMA: | 450.57 | Sell |
IPX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.67 | Buy |
20-day SMA: | 29.83 | Buy |
50-day SMA: | 26.65 | Buy |
200-day SMA: | 18.66 | Buy |
8-day EMA: | 32.56 | Buy |
20-day EMA: | 30.3 | Buy |
50-day EMA: | 27.32 | Buy |
200-day EMA: | 20.04 | Buy |
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, an increase this year of $18.20 per share, and an increase next year of $2.07 per share.
IperionX Earnings Growth & IPX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.13 per share.
Vertex Pharmaceuticals Technical Analysis
Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
IperionX Technical Analysis
Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |